Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flavin-containing monooxygenase and ascorbic acid deficiency. Qualitative and quantitative differences.

J I Brodfuehrer1, V G Zannoni

  • 1Department of Pharmacology, University of Michigan, Ann Arbor 48109.

Biochemical Pharmacology
|October 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of clinafloxacin after single and multiple doses.

Antimicrobial agents and chemotherapy·2001
Same author

Pharmacokinetics of clinafloxacin enantiomers in humans.

Journal of clinical pharmacology·1999
Same author

Achiral and chiral high-performance liquid chromatographic methods for clinafloxacin, a fluoroquinolone antibacterial, in human plasma.

Journal of chromatography. B, Biomedical sciences and applications·1998
Same author

High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine.

Journal of chromatography. B, Biomedical applications·1995
Same author

Ascorbic acid deficiency and hepatic UDP-glucuronyl transferase. Qualitative and quantitative differences.

Biochemical pharmacology·1990
Same author

Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.

Drug metabolism and disposition: the biological fate of chemicals·1990
Same journal

Mapk-driven remodeling of mitochondrial dynamics in melanoma: implications for metabolic plasticity and response to targeted therapy.

Biochemical pharmacology·2026
Same journal

Unraveling the multifaceted roles of the aryl hydrocarbon receptor in the central nervous system: neurogenesis, neural function, and disease.

Biochemical pharmacology·2026
Same journal

4-DMB, a diclofenac derivative, alleviates DSS-induced ulcerative colitis in mice by binding TNFR1 to inhibit inflammation.

Biochemical pharmacology·2026
Same journal

Calceolarioside B alleviates airway barrier dysfunction and inflammation via targeting P2Y<sub>6</sub>R in OVA-triggered asthma.

Biochemical pharmacology·2026
Same journal

The dual-faced pyruvate kinase M2 in tumors: From cytoplasmic metabolic gatekeeper to nuclear transcriptional coactivator.

Biochemical pharmacology·2026
Same journal

A [<sup>68</sup>Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens.

Biochemical pharmacology·2026
See all related articles

Ascorbic acid deficiency alters guinea pig hepatic flavin-containing monooxygenase (FMO) quantity and quality. This vitamin C deficiency impacts FMO enzyme stability and cofactor requirements, affecting drug metabolism.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nutritional Science

Background:

  • Flavin-containing monooxygenase (FMO) enzymes play a crucial role in the metabolism of xenobiotics and endogenous compounds.
  • Ascorbic acid (vitamin C) is an essential cofactor for various biological processes, and its deficiency can lead to significant physiological changes.
  • Previous research suggests a link between ascorbic acid status and FMO activity, but the specific molecular mechanisms remain unclear.

Purpose of the Study:

  • To investigate the qualitative and quantitative effects of ascorbic acid deficiency on guinea pig hepatic flavin-containing monooxygenase (FMO).
  • To characterize the kinetic properties, stability, and cofactor dependency of FMO isolated from ascorbate-supplemented and -deficient guinea pigs.

Main Methods:

  • Purification of hepatic FMO from guinea pigs with varying ascorbic acid levels using DEAE-cellulose and blue agarose chromatography.

Related Experiment Videos

  • Kinetic studies to determine the apparent Km for dimethylaniline and NADPH.
  • Assessment of exogenous FAD requirement, enzyme stability at -20°C, and sensitivity to time-dependent nonlinearity.
  • SDS-PAGE to evaluate protein quantity and molecular weight.

    • Main Results:

    • Ascorbic acid deficiency led to qualitative and quantitative alterations in hepatic FMO.
    • Purified FMO from deficient animals showed an increased requirement for exogenous FAD (15% vs. 5%) and enhanced sensitivity to time-dependent nonlinearity.
    • The deficient FMO enzyme exhibited reduced stability and a decreased quantity, evidenced by lower recovered activity and protein staining intensity.

    Conclusions:

    • Ascorbic acid deficiency significantly impacts guinea pig hepatic FMO, affecting its cofactor dependency, stability, and overall quantity.
    • These alterations in FMO may have implications for drug metabolism and the detoxification of various compounds in vitamin C deficient states.
    • Further research is warranted to elucidate the precise molecular mechanisms underlying these FMO changes in ascorbic acid deficiency.